Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets

被引:1
作者
Dalakoti, Mayank [1 ,2 ,3 ]
Virani, Salim [4 ,5 ,6 ]
机构
[1] Natl Univ Heart Ctr, Dept Cardiol, Singapore, Singapore
[2] Ng Teng Fong Gen Hosp, Dept Med, Singapore, Singapore
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
[4] Aga Khan Univ, Dept Med, Karachi, Pakistan
[5] Texas Heart Inst, Houston, TX USA
[6] Baylor Coll Med, Sect Cardiovasc Res, Houston, TX USA
来源
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2024年 / 19卷
关键词
Keywords; LDL-C; Primary prevention; Primordial prevention; Preventive cardiology; Lipids; CHOLESTEROL; MANAGEMENT;
D O I
10.1016/j.ajpc.2024.100720
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 16 条
[1]  
Burger PM, 2023, Eur Heart J, V44
[2]   Impact of Lipids on Cardiovascular Health JACC Health Promotion Series (Reprinted from J Am Coll Cardiol, vol 72, pg 1141-56, 2018) [J].
Ference, Brian A. ;
Graham, Ian ;
Tokgozoglu, Lale ;
Catapano, Alberico L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (23) :2980-2995
[3]   Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease A Mendelian Randomization Analysis [J].
Ference, Brian A. ;
Yoo, Wonsuk ;
Alesh, Issa ;
Mahajan, Nitin ;
Mirowska, Karolina K. ;
Mewada, Abhishek ;
Kahn, Joel ;
Afonso, Luis ;
Williams, Kim Allan, Sr. ;
Flack, John M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (25) :2631-2639
[4]   Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE [J].
Gaba, Prakriti ;
O'Donoghue, Michelle L. ;
Park, Jeong-Gun ;
Wiviott, Stephen D. ;
Atar, Dan ;
Kuder, Julia F. ;
Im, KyungAh ;
Murphy, Sabina A. ;
De Ferrari, Gaetano M. ;
Gaciong, Zbigniew A. ;
Toth, Kalman ;
Gouni-Berthold, Ioanna ;
Lopez-Miranda, Jose ;
Schiele, Francois ;
Mach, Francois ;
Flores-Arredondo, Jose H. ;
Lopez, J. Antonio G. ;
Elliott-Davey, Mary ;
Wang, Bei ;
Monsalvo, Maria Laura ;
Abbasi, Siddique ;
Giugliano, Robert P. ;
Sabatine, Marc S. .
CIRCULATION, 2023, 147 (16) :1192-1203
[5]   Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial [J].
Kazi, Dhruv S. ;
Penko, Joanne ;
Coxson, Pamela G. ;
Moran, Andrew E. ;
Ollendorf, Daniel A. ;
Tice, Jeffrey A. ;
Bibbins-Domingo, Kirsten .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (08) :748-750
[6]  
Kharlamov A, 2020, EUR HEART J, V41, P1454
[7]   Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe [J].
Khunti, Kamlesh ;
Danese, Mark D. ;
Kutikova, Lucie ;
Catterick, David ;
Sorio-Vilela, Francisco ;
Gleeson, Michelle ;
Seshasai, Sreenivasa Rao Kondapally ;
Brownrigg, Jack ;
Ray, Kausik K. .
JAMA NETWORK OPEN, 2018, 1 (08) :e185554
[8]   Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia [J].
Kosmas, Constantine E. ;
Silverio, Delia ;
Ovalle, Julio ;
Montan, Peter D. ;
Guzman, Eliscer .
PATIENT PREFERENCE AND ADHERENCE, 2018, 12 :2263-2266
[9]   Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years [J].
Mendieta, Guiomar ;
Pocock, Stuart ;
Mass, Virginia ;
Moreno, Andrea ;
Owen, Ruth ;
Garcia-Lunar, Ines ;
Lopez-Melgar, Beatriz ;
Fuster, Jose J. ;
Andres, Vicente ;
Perez-Herreras, Cristina ;
Bueno, Hector ;
Fernandez-Ortiz, Antonio ;
Sanchez-Gonzalez, Javier ;
Garcia-Alvarez, Ana ;
Ibanez, Borja ;
Fuster, Valentin .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (22) :2069-2083
[10]   Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease [J].
Michos, Erin D. ;
McEvoy, John W. ;
Blumenthal, Roger S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16) :1557-1567